Hwanin Pharmaceutical Reports 9.7 Billion KRW Operating Profit in 1Q, Down 19.5% YoY
[Asia Economy Reporter Kwon Jae-hee] Hwanin Pharmaceutical announced on the 28th that its sales revenue for the first quarter of 2022 reached 48.845 billion KRW, and operating profit was 9.716 billion KRW. Sales revenue increased by 8% compared to the same period last year, while operating profit decreased by 19.5%.
Hot Picks Today
At President Lee's Call to "Give Enough to Shock," Whistleblower Rewards Become a Real Lottery
- "If Both Spouses Work There, How Much Would They Make?" "They Earn More Than Me, and I'm a Doctor"... Envy Erupts Over Samsung Electronics' Bonus
- Lived as Family for Over 30 Years... Daughter-in-Law Cast Aside After Husband's Death
- "Going to Work Every Day Is Terrifying"... Starbucks Frontline Workers Vent Frustration Amid 'Tank Day' Backlash
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
